Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 2 |
TSMC
TSM
|
+$429M |
| 3 |
Microsoft
MSFT
|
+$404M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$319M |
| 5 |
NVIDIA
NVDA
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$508M |
| 2 |
Apple
AAPL
|
+$204M |
| 3 |
SEE
Sealed Air
SEE
|
+$179M |
| 4 |
HOLX
Hologic
HOLX
|
+$166M |
| 5 |
Advanced Micro Devices
AMD
|
+$162M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.15% |
| 2 | Industrials | 3.74% |
| 3 | Financials | 3.34% |
| 4 | Consumer Discretionary | 2.9% |
| 5 | Healthcare | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
PUT
Owens Corning
OC
$11.7B
| $223K | ﹤0.01% |
1,400
-3,100
| -69% | -$377K |
|
3252
CALL
Ventas
VTR
$47.7B
| $222K | ﹤0.01% |
2,500
-900
| -26% | -$76.7K |
|
3253
CALL
TE Connectivity
TEL
$58.9B
| $222K | ﹤0.01% |
+1,100
| New | +$234K |
|
3254
CALL
Century Aluminum
CENX
$4.35B
| $221K | ﹤0.01% |
+4,800
| New | +$289K |
|
3255
Covenant Logistics
CVLG
$893M
| $220K | ﹤0.01% |
4,986
-68,522
| -93% | -$2.5M |
|
|
SHAZ
3256
PUT
SharonAI Holdings
SHAZ
$2.11B
| $220K | ﹤0.01% |
+2,600
| New | +$147K |
|
|
PPTA
3257
PUT
Perpetua Resources
PPTA
$3.21B
| $220K | ﹤0.01% |
10,600
-16,400
| -61% | -$445K |
|
3258
CALL
Keurig Dr Pepper
KDP
$43.6B
| $219K | ﹤0.01% |
6,700
-14,100
| -68% | -$411K |
|
3259
PUT
Replimune Group
REPL
$1.39B
| $219K | ﹤0.01% |
19,800
-30,200
| -60% | -$185K |
|
3260
Evolus
EOLS
$554M
| $219K | ﹤0.01% |
+31,547
| New | +$186K |
|
3261
CALL
TC Energy
TRP
$64.6B
| $219K | ﹤0.01% |
3,300
-600
| -15% | -$39.7K |
|
3262
PUT
Ametek
AME
$54.9B
| $218K | ﹤0.01% |
900
-1,500
| -63% | -$346K |
|
3263
Corporacion America
CAAP
$3.83B
| $217K | ﹤0.01% |
8,606
-10,629
| -55% | -$273K |
|
3264
PUT
Intellia Therapeutics
NTLA
$1.8B
| $217K | ﹤0.01% |
+12,800
| New | +$179K |
|
3265
PUT
Nektar Therapeutics
NKTR
$2.53B
| $216K | ﹤0.01% |
3,100
-2,600
| -46% | -$190K |
|
3266
CALL
Invesco
IVZ
$14.1B
| $216K | ﹤0.01% |
+8,200
| New | +$217K |
|
3267
PUT
Noble Corp
NE
$7.39B
| $216K | ﹤0.01% |
5,800
-1,300
| -18% | -$62.1K |
|
3268
CALL
Structure Therapeutics
GPCR
$3.5B
| $215K | ﹤0.01% |
+4,000
| New | +$177K |
|
3269
CALL
Omega Healthcare
OHI
$14.1B
| $215K | ﹤0.01% |
4,500
-38,000
| -89% | -$1.76M |
|
3270
PUT
Matador Resources
MTDR
$7.22B
| $214K | ﹤0.01% |
4,300
-12,400
| -74% | -$705K |
|
3271
Third Coast Bancshares
TCBX
$758M
| $214K | ﹤0.01% |
5,285
-39,144
| -88% | -$1.53M |
|
3272
CALL
Ascendis Pharma A/S
ASND
$16.6B
| $213K | ﹤0.01% |
800
-33,300
| -98% | -$7.78M |
|
3273
CALL
Darling Ingredients
DAR
$10.4B
| $213K | ﹤0.01% |
3,900
-5,100
| -57% | -$304K |
|
3274
CALL
Root
ROOT
$864M
| $212K | ﹤0.01% |
+3,800
| New | +$203K |
|
3275
PUT
Vornado Realty Trust
VNO
$7.07B
| $212K | ﹤0.01% |
+5,400
| New | +$175K |
|
Similar funds
Paul Tudor Jones's Q2 2026 Portfolio in Review
As of Q2 2026, Paul Tudor Jones held 4,450 positions worth $71.9B, up 33% from $53.9B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Paul Tudor Jones deployed $8.74B of net new capital in Q2 2026, opening 936 new positions and adding to 1,167 existing holdings. Its largest new stake was Oracle: 1,262,004 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $508M trimmed.
- Paul Tudor Jones's largest Q2 2026 buy was Oracle: 1,262,004 shares worth $185M.
- Paul Tudor Jones added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $1.03B increase.
- Paul Tudor Jones's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $508M.
- Paul Tudor Jones fully exited Sealed Air in Q2 2026, selling an estimated $179M.
- Paul Tudor Jones's ten largest holdings make up 35% of its $71.9B portfolio in Q2 2026.
- Paul Tudor Jones opened 936 new positions and closed 993 in Q2 2026.
- Paul Tudor Jones's portfolio value rose 33% quarter-over-quarter to $71.9B.
Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.